NCT02655770View on ClinicalTrials.gov

Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Diabetes Mellitus Type 2Diastolic DysfunctionCardiac MRIMyocardial Perfusion

Interventions

DRUG

Liraglutide

DRUG

Placebo

Trial Locations (1)

210

The department of cardiology, Rigshospitalet Denmark, Copenhagen Ø

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Slagelse Hospital

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Rigshospitalet, Denmark

OTHER